Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials

Markus Schurks, instructor of medicine, Robert J Glynn, associate professor of medicine and biostatistics, Pamela M Rist, doctoral student in epidemiology, Christophe Tzourio, senior director of research, Tobias Kurth, director of researchCorrespondence to: M Schurks mschuerks@rics.bwh.harvard.edu, T Kurth tobias.kurth@upmc.fr

Fig 3 Relative risks of the effect of vitamin E on haemorrhagic stroke for individual trials and for the pooled population

Abstract

Objective

To evaluate the effect of vitamin E supplementation on incident total, ischaemic, and haemorrhagic stroke.

Design

Systematic review and meta-analysis of randomised, placebo controlled trials published until January 2010.

Data sources

Electronic databases (Medline, Embase, Cochrane Central Register of Controlled Trials) and reference lists of trial reports.Selection criteria Randomised, placebo controlled trials with ≥1 year of follow-up investigating the effect of vitamin E on stroke.

Review methods and data extraction

Two investigators independently assessed eligibility of identified trials. Disagreements were resolved by consensus. Two different investigators independently extracted data. Risk ratios (and 95% confidence intervals) were calculated for each trial based on the number of cases and non-cases randomised to vitamin E or placebo. Pooled effect estimates were then calculated.

Results

Nine trials investigating the effect of vitamin E on incident stroke were included, totalling 118 765 participants (59 357 randomised to vitamin E and 59 408 to placebo). Among those, seven trials reported data for total stroke and five trials each for haemorrhagic and ischaemic stroke. Vitamin E had no effect on the risk for total stroke (pooled relative risk 0.98 (95% confidence interval 0.91 to 1.05), P=0.53). In contrast, the risk for haemorrhagic stroke was increased (pooled relative risk 1.22 (1.00 to 1.48), P=0.045), while the risk of ischaemic stroke was reduced (pooled relative risk 0.90 (0.82 to 0.99), P=0.02). There was little evidence for heterogeneity among studies. Meta-regression did not identify blinding strategy, vitamin E dose, or morbidity status of participants as sources of heterogeneity. In terms of absolute risk, this translates into one additional haemorrhagic stroke for every 1250 individuals taking vitamin E, in contrast to one ischaemic stroke prevented per 476 individuals taking vitamin E.

Conclusion In this meta-analysis, vitamin E increased the risk for haemorrhagic stroke by 22% and reduced the risk of ischaemic stroke by 10%. This differential risk pattern is obscured when looking at total stroke. Given the relatively small risk reduction of ischaemic stroke and the generally more severe outcome of haemorrhagic stroke, indiscriminate widespread use of vitamin E should be cautioned against.

Fuente: BMJ 2010; 341:c5702 doi: 10.1136/bmj.c5702 (Published 4 November 2010)